Virginia Retirement Systems’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
+4,500
New +$976K 0.01% 724
2025
Q3
Sell
-2,100
Closed -$219K 938
2025
Q2
$219K Buy
+2,100
New +$222K ﹤0.01% 889
2020
Q4
Sell
-3,100
Closed -$221K 1109
2020
Q3
$221K Buy
+3,100
New +$242K ﹤0.01% 1011
2020
Q1
Sell
-12,900
Closed -$1.33M 1090
2019
Q4
$1.33M Sell
12,900
-5,100
-28% -$206K 0.01% 578
2019
Q3
$364K Buy
18,000
+3,300
+22% +$84.8K ﹤0.01% 973
2019
Q2
$379K Buy
+14,700
New +$295K ﹤0.01% 986

Other funds holding AXSM

Virginia Retirement Systems's AXSM Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 4,500 shares worth $1.1M. The stake represents 0.01% of the portfolio and ranks #724 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in AXSM as recently as Q2 2025.

Virginia Retirement Systems first reported a position in AXSM in Q2 2019 and has held it in 6 quarters since. The position peaked at $1.33M in Q4 2019. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Virginia Retirement Systems held 4,500 shares of Axsome Therapeutics worth $1.1M as of Q2 2026.
  • Axsome Therapeutics was a new Virginia Retirement Systems position in Q2 2026.
  • Axsome Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #724 holding.
  • Virginia Retirement Systems first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 6 quarters since.
  • Virginia Retirement Systems's Axsome Therapeutics position peaked at $1.33M in Q4 2019.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.